ACAP1在卵巢浆液性囊腺癌中的表达及其意义
李润洲, 周欣中国医科大学附属盛京医院妇产科, 沈阳 110004
收稿日期:
2021-05-19出版日期:
2021-10-30发布日期:
2021-10-11通讯作者:
周欣E-mail:drzhouxin@163.com作者简介:
李润洲(1995-),女,医师,硕士.基金资助:
国家自然科学基金(82072885);辽宁省重点研发计划(2020JH2/10300124);沈阳市科技计划(19-112-4-104)关键词: ACAP1, 卵巢浆液性囊腺癌, 生物信息学分析
Abstract: Objective To detect the expression of ADP-ribosylation factor GTPase-activating protein with coiled-coil, ankyrin repeat and pleckstrin homology domains 1 (ACAP1) in ovarian serous carcinoma, and to determine the relationship between ACAP1 and the occurrence and development of ovarian serous carcinoma. Methods The Oncomine database was used to analyze the mRNA expression of ACAP1 in ovarian cancer. The cBioportal database was used to analyze genetic variations in ACAPs. The Genemania database was used to analyze the gene-gene interaction network of ACAPs. The expression of ACAP1 in tissues was studied by immunohistochemistry. Results The mRNA expression of ACAP1 in ovarian cancer tissues was higher than that in normal ovarian tissues. Many types of gene mutations were detected in the ACAP family. Using the Genemania database, we constructed the gene-gene interaction network of ACAPs; the five genes most closely related to the ACAP family were GULP1, ARF6, RAB11FIP3, SLC2A4, and VAMP3. The expression of ACAP1 in ovarian serous carcinoma tissue was higher than that in normal ovarian tissue (P < 0.001). The high expression of ACAP1 in the primary tumor was significantly associated with poor prognosis (P=0.037). The expression of ACAP1 in ovarian cancer metastases was higher than that in the primary ovarian cancer (P < 0.001). Conclusion ACAP1 may be related to the occurrence and development of ovarian serous carcinoma. It has potential as a novel diagnostic and therapeutic target for ovarian cancer.
Key words: ACAP1, ovarian serous cystadenocarcinoma, bioinformatic analysis
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=2849